SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-095538
Filing Date
2024-08-12
Accepted
2024-08-12 17:15:48
Documents
7
Effectiveness Date
2024-08-12

Document Format Files

Seq Description Document Type Size
1 S-8 sabs_s-8_fy24aug.htm S-8 124921
2 EX-5.1 sabs-ex5_1.htm EX-5.1 30501
3 EX-23.1 sabs-ex23_1.htm EX-23.1 3311
4 EX-99.1 sabs-ex99_1.htm EX-99.1 225545
5 EX-FILING FEES sabs-exfiling_fees.htm EX-FILING FEES 44323
6 GRAPHIC img84541401_0.jpg GRAPHIC 18837
7 GRAPHIC img84541401_1.jpg GRAPHIC 18837
  Complete submission text file 0000950170-24-095538.txt   481934
Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281499 | Film No.: 241197930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)